Genentech to Apply for New Cancer Indication for Avastin
Mar 15th, 2008 by Kathy
Source: http://fdanews.com/newsletter/article?articleId=104962…
Genentech announced it will submit a supplemental Biologics License Application (sBLA) this year for accelerated FDA approval to use its oncology drug Avastin to treat relapsed glioblastoma multiforme (GBM).
